Director/PDMR Shareholding

Paris, France and Camberley, UK – 13 November 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on 13 November 2020, James McCarthy (PDMR), a corporate consultant, acquired 10,000 ordinary shares of €1/15 each in the Company at an average price of £8.953 per share.  The resultant beneficial shareholding of Mr McCarthy is 10,000 ordinary shares representing 0.01% of the Company’s issued share capital.